1. Home
  2. IMMP vs PMM Comparison

IMMP vs PMM Comparison

Compare IMMP & PMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMMP
  • PMM
  • Stock Information
  • Founded
  • IMMP 1987
  • PMM 1989
  • Country
  • IMMP Australia
  • PMM United States
  • Employees
  • IMMP N/A
  • PMM N/A
  • Industry
  • IMMP Biotechnology: Pharmaceutical Preparations
  • PMM Investment Managers
  • Sector
  • IMMP Health Care
  • PMM Finance
  • Exchange
  • IMMP Nasdaq
  • PMM Nasdaq
  • Market Cap
  • IMMP 304.0M
  • PMM 287.2M
  • IPO Year
  • IMMP N/A
  • PMM N/A
  • Fundamental
  • Price
  • IMMP $2.17
  • PMM $6.16
  • Analyst Decision
  • IMMP Buy
  • PMM
  • Analyst Count
  • IMMP 2
  • PMM 0
  • Target Price
  • IMMP $8.50
  • PMM N/A
  • AVG Volume (30 Days)
  • IMMP 147.6K
  • PMM 118.3K
  • Earning Date
  • IMMP 12-27-2024
  • PMM 01-01-0001
  • Dividend Yield
  • IMMP N/A
  • PMM 4.68%
  • EPS Growth
  • IMMP N/A
  • PMM N/A
  • EPS
  • IMMP N/A
  • PMM 0.23
  • Revenue
  • IMMP $2,563,302.00
  • PMM N/A
  • Revenue This Year
  • IMMP N/A
  • PMM N/A
  • Revenue Next Year
  • IMMP $10.84
  • PMM N/A
  • P/E Ratio
  • IMMP N/A
  • PMM $26.52
  • Revenue Growth
  • IMMP 9.59
  • PMM N/A
  • 52 Week Low
  • IMMP $1.66
  • PMM $5.00
  • 52 Week High
  • IMMP $3.34
  • PMM $6.42
  • Technical
  • Relative Strength Index (RSI)
  • IMMP 55.07
  • PMM 37.64
  • Support Level
  • IMMP $2.00
  • PMM $6.26
  • Resistance Level
  • IMMP $2.39
  • PMM $6.43
  • Average True Range (ATR)
  • IMMP 0.13
  • PMM 0.08
  • MACD
  • IMMP 0.01
  • PMM -0.02
  • Stochastic Oscillator
  • IMMP 54.17
  • PMM 0.00

About IMMP Immutep Limited

Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.

About PMM Putnam Managed Municipal Income Trust

Putnam Managed Municipal Income Trust is a closed-end management investment company. Its investment objective is to seek a high level of current income exempt from federal income tax by investing in a diversified portfolio of tax-exempt municipal securities. The Fund invests in various sectors such as healthcare, retirement community, private higher education, housing-backed, essential service utilities, and state-backed bonds.

Share on Social Networks: